Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Paneni

Showing results (131-140 of 215) with videos related to

Pageof 22
Sort By:
International Journal of Cardiology|July 27, 2018
Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66<sup>Shc</sup>Sarah Costantino, Francesco Paneni, Katharyn Mitchell, et al.
International Journal of Cardiology|March 12, 2011
Impact of dialysis modality on the appropriateness of left ventricular mass in patients with end-stage renal diseaseFrancesco Paneni, Mario Gregori, Giuseppino Massimo Ciavarella, et al.
Heart Failure Clinics|November 20, 2025
Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart FailureLudovica Di Venanzio, Natalia Atzemian, Bennet Y Weber, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 16, 2026
The prognostic value of systemic inflammatory response index (SIRI) in acute coronary syndrome patients treated with primary percutaneous coronary intervention: a meta-analysis and systematic reviewChenming Hu, Qianling Ye, Shunjie You, et al.
Iscience|October 31, 2025
Unlocking metabolic flexibility in heart failure with preserved ejection fraction: Bridging fundamental mechanisms to clinical innovationJunyan Xia, Yibing Nong, Jun Teng, et al.
Progress in Cardiovascular Diseases|March 8, 2023
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)Maciej Banach, Peter E Penson, Michel Farnier, et al.
Cardiovascular Diabetology|June 13, 2025
Interleukin-1β in circulating mononuclear cells predicts steatotic liver disease improvement after weight loss in subjects with obesity and prediabetes or type 2 diabetesPaola Giustina Simeone, Sarah Costantino, Rossella Liani, et al.
Pharmacological Research|July 3, 2025
Messenger RNA (mRNA) based therapeutics in transforming cardiovascular care: Progress, regulatory challenges and future perspectivesMudassir Khan, Umberto M Musazzi, Sara Manellari, et al.
Circulation. Cardiovascular Genetics|December 5, 2014
Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitusFrancesco Paneni, Sarah Costantino, Rodolfo Battista, et al.
American Journal of Nephrology|October 1, 2010
Right ventricular dysfunction in patients with end-stage renal diseaseFrancesco Paneni, Mario Gregori, Giuseppino Massimo Ciavarella, et al.
Pageof 22

Showing results (131-140 of 215) with videos related to

Sort By:
Pageof 22
International Journal of Cardiology|July 27, 2018
Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66<sup>Shc</sup>Sarah Costantino, Francesco Paneni, Katharyn Mitchell, et al.
International Journal of Cardiology|March 12, 2011
Impact of dialysis modality on the appropriateness of left ventricular mass in patients with end-stage renal diseaseFrancesco Paneni, Mario Gregori, Giuseppino Massimo Ciavarella, et al.
Heart Failure Clinics|November 20, 2025
Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart FailureLudovica Di Venanzio, Natalia Atzemian, Bennet Y Weber, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 16, 2026
The prognostic value of systemic inflammatory response index (SIRI) in acute coronary syndrome patients treated with primary percutaneous coronary intervention: a meta-analysis and systematic reviewChenming Hu, Qianling Ye, Shunjie You, et al.
Iscience|October 31, 2025
Unlocking metabolic flexibility in heart failure with preserved ejection fraction: Bridging fundamental mechanisms to clinical innovationJunyan Xia, Yibing Nong, Jun Teng, et al.
Progress in Cardiovascular Diseases|March 8, 2023
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)Maciej Banach, Peter E Penson, Michel Farnier, et al.
Cardiovascular Diabetology|June 13, 2025
Interleukin-1β in circulating mononuclear cells predicts steatotic liver disease improvement after weight loss in subjects with obesity and prediabetes or type 2 diabetesPaola Giustina Simeone, Sarah Costantino, Rossella Liani, et al.
Pharmacological Research|July 3, 2025
Messenger RNA (mRNA) based therapeutics in transforming cardiovascular care: Progress, regulatory challenges and future perspectivesMudassir Khan, Umberto M Musazzi, Sara Manellari, et al.
Circulation. Cardiovascular Genetics|December 5, 2014
Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitusFrancesco Paneni, Sarah Costantino, Rodolfo Battista, et al.
American Journal of Nephrology|October 1, 2010
Right ventricular dysfunction in patients with end-stage renal diseaseFrancesco Paneni, Mario Gregori, Giuseppino Massimo Ciavarella, et al.
Pageof 22